`UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC  20549



Form 10-QSB


(Mark One)

 [X]     QUARTERLY  REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 For the quarter year ended March 31, 2001.

 [  ]     TRANSITION  REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 For the transition period from _______ to ________


Commission File Number: 2-89616

CONSOLIDATED MEDICAL MANAGEMENT, INC.
(Exact name of Registrant as specified in charter)


MONTANA                                             82-0369233
State or other jurisdiction of                    IRS Employer I.D. No.
incorporation or organization

               200 Lafayette #777, Baton Rouge, LA                  70801
            (Address of principal executive offices)             (Zip Code)


Issuer's telephone number, including area code:           (225) 275-3857


Check whether the Issuer (1) has filed all reports required to be filed by
section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. (1) Yes [X]
No [  ]     (2) Yes [X]   No [  ]


State the number of shares outstanding of each of the Issuer's classes of
common equity as of the latest practicable date:  At  May 16, 2001, there were
10,626,247 common shares of the Registrant outstanding.




Consolidated Medical Management, Inc.
Baton Rouge, Louisiana



TABLE OF CONTENTS


        Part I -     Financial Information                             Page
        Item 1.      Financial Statements
                     Report of Independent Accountant                    4
                     Consolidated Balance Sheets                         5
                     Consolidated Statements of Operations               6
                     Consolidated Statements of Cash Flows               7
                     Consolidated Statements of Changes in Stockholders'
                      Equity (Deficit)                                   8
                     Notes to Consolidated Financial Statements          9
        Item 2.           Management's Discussion and Analysis
                of Financial Condition and Results of Operation          14

        Part II -     Other Information

        Item 2.          Change in Securities                            16

        Item 5.          Other Information                               16

        Item 6.          Exhibits and Reports on Form 8-K                16

                     Signature                                           17





P A R T     I

FINANCIAL INFORMATION

ITEM 1.  FINANCIAL INFORMATION

The consolidated financial statements for Consolidated Medical Management,
Inc. (the Company) included herein are unaudited but reflect, in management's
opinion, all adjustments, consisting only of normal recurring adjustments,
that are necessary for a fair presentation of the Company's financial position
and the results of its operations for the interim periods presented.  Because
of the nature of the Company's business, the results of operations for the
three months ended March 31, 2001 are not necessarily indicative of the
results that may be expected for the full fiscal year.  The financial
statements included herein should be read in conjunction with the financial
statements and notes thereto included in the Company's Annual Report on Form
10-KSB for the year ended December 31, 2000 (2000 Form 10-KSB).










[ THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY.]






















REPORT OF INDEPENDENT ACCOUNTANT



To the Board of Directors
Consolidated Medical Management, Inc.
(A Montana Corporation)
Baton Rouge, Louisiana


We have made a review of the consolidated balance sheet of Consolidated
Medical Management, Inc. as of March 31, 2001,and the related consolidated
statements of operations and cash flows for the three months period ended
March 31, 2001 and 2000, in accordance with the standards established by the
American Institute of Certified Public Accountants.  These financial
statements are the responsibility of the Company's management.

A review of interim financial information consists principally of obtaining an
understanding of the system for the preparation of interim financial
information, applying analytical review procedures to financial data, and
making inquiries of persons responsible for financial and accounting matters.
It is substantially less in scope than an audit in accordance with generally
accepted auditing standards,  the objective of which is the expression of an
opinion regarding the financial statements taken as a whole.  Accordingly, we
do not express such an opinion.

Based on our review, we are not aware of any material modifications that
should be made to the consolidated financial statements referred to above for
them to be in conformity with generally accepted accounting principles.

We have previously audited, in accordance with generally accepted auditing
standards, the consolidated balance sheet as of December 31, 2000, and the
related consolidated statements of income, cash flows and changes in common
shareholders' equity (deficit) for the year then ended (not presented herein);
and in our report dated April 30, 2000, we expressed a qualified opinion on
those financial statements.  In our opinion, the information set forth in the
accompanying balance sheet as of March 31, 2001, is fairly stated in all
material respects in relation to the balance sheet from which it has been
derived.




Clyde Bailey P.C



San Antonio, Texas
May 16, 2000


CONSOLIDATED MEDICAL MANAGEMENT, INC.
(A Montana Corporation)
Consolidated Balance Sheet

(Unaudited)

     ASSETS
                                             March 31, 2001     December 31, 2000
     Current Assets
          Cash                                     $528            $1,724

         Total Current Assets                       528             1,724

     Fixes Assets:                                    -            17,415

     Other Assets                                     -                 -

         Total Assets                              $528           $19,139

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

     Current Liabilities
          Notes Payable-Current Portion         $25,767           $25,767
          Accounts Payable                      150,687           275,300
          Accrued Expenses                      135,406           115,372
          Convertible Debentures                465,000           465,000
           and Notes Payable-Current Portion

         Total Current Liabilities              776,860           881,439

          Notes Payable - Long Term Portion      54,726            54,726
               Long-Term Portion

         Total Long-Term Liabilities             54,726            54,726

         Total Liabilities                     $831,586          $936,165

     Commitments and Contingencies:                                     -

     Stockholders' Equity
          Common Stock                          $10,626           $15,026

          Additional Paid-in-Capital          2,516,111         2,915,711
          Retained Earnings (Deficit)        (3,357,795)       (3,847,763)

         Total Stockholders' Equity (Deficit)  (831,058)         (917,026)

         Total Liabilities and
          Stockholders' Equity (Deficit)           $528           $19,139


See accompanying notes to Consolidated Financial Statements.



CONSOLIDATED MEDICAL MANAGEMENT, INC.
(A Montana Corporation)
Consolidated Statement of Operations
(Unaudited)



                                             Three Months ended March 31,
                                                  2001          2000

Revenues                                         $-            $76,287

Operating Expenses
     Personnel Costs                              -             68,928
     Depreciation and Amortization                -              8,086
     Legal and Professional                     16,000          50,175
     Office Expense                              1,429          25,603
     Occupancy                                    -              6,114

     Total Operating Expenses                  $17,429        $158,906

Income (Loss) from Operations                  (17,429)        (82,619)

Other Income (Expenses)
     Other                                     528,387            -
     Interest Expense                          (20,990)        (20,799)
     Interest Income                              -              1,812

                                               507,397         (18,987)

Income (Loss) before Income Taxes             $489,968       $(101,606)

Income Tax Expense                                -               -

Net Income (Loss)                             $489,968       $(101,606)

Net Income (Loss) per Share                    $0.0444        $(0.0023)


See accompanying notes to Consolidated Financial Statements.



CONSOLIDATED MEDICAL MANAGEMENT, INC.
(A Montana Corporation)
Consolidated Statement of Cash Flows
(Unaudited)

                                                  Three Months ended March 31,
                                                       2001          2000

Cash Flows from Operating Activities:
     Net Income (Loss)                                   $489,968    $(101,606)
     Adjustments to Reconcile Net Income
      (Loss) to Net Cash Provided by
          Operating Activities:
               Depreciation and Amortization                -            8,086
               Non Cash Consulting and Services
                Paid by Stock Issue                         -            8,600
               (Increase) Decrease in Receivables           -           (4,608)
               (Decrease) Increase in Accounts Payable   (124,613)      10,463
               (Increase) Decrease in Interest Payable     20,034       20,910
               (Increase) Decrease in Accrued Expenses      -          (18,171)

          Net Cash Provided (Used) by Operating
           Activities                                    $385,389     $(76,326)


Cash Flows from Investing Activities:

     Assets Disposed                                       17,415            -

          Net Cash Provided (Used) by Investing
           Activities                                     $17,415           $-


Cash Flows from Financing Activities:

     Payments on Long-Term Debt                               -              -
     Common Stock                                        (404,000)     131,791

          Net Cash Provided (Used) by Financing
           Activities                                   $(404,000)    $131,791

Net Increase (Decrease) in Cash                           $(1,196)     $55,465

Cash, Beginning of period                                   1,724       25,540

Cash, End of period                                          $528      $81,005

Supplemental Disclosure of Cash Flow Information
     Cash Paid During the Period for:
          Interest                                           $956           $-
          Income Taxes                                       $-             $-

Supplemental Disclosure of Non-Cash Financing
Information
     In the quarter ended March 31, 2000 and 1999,
     the Company issued common stock for consulting services
     rendered totaling $8,600 and $84,168 respectively.

See accompanying notes to Consolidated Financial Statements.

CONSOLIDATED MEDICAL MANAGEMENT, INC.
(A Montana Corporation)
Consolidated Statements of Changes in Stockholders' Equity
(Deficit)
(Unaudited)


                                                                            Retained
                                        Common Stock      Additional Paid   Earnings
                                   Shares          Amount   In Capital      (Deficit)          Total

Balance December 31, 1999            8,046,247     8,046  $2,689,025     $(2,845,828)      $(148,756)

Stock issued for directors fees      4,530,000     4,530      55,470                          60,000

Stock issued for payables              450,000       450      73,216                          73,665

Stock issued for Cash                2,000,000     2,000      98,000                         100,000

Net Income (Loss)                                             (1,001,935)                 (1,001,935)

Balance December 31, 2000           15,026,247    15,026      2,915,711   (3,847,763)       (917,026)

Stock Cancelled - Former President  (4,000,000)   (4,000)                                     (4,000)
 and CEO

Stock Cancelled                       (400,000)     (400)      (399,600)                    (400,000)

Net Income (Loss)                                                                489,968     489,968

Balance March 31, 2001              10,626,247    10,626    $2,516,111       $(3,357,795)  $(831,058)



See accompanying notes to Consolidated Financial Statements.


Consolidated Medical Management, Inc
NOTES TO FINANCIAL STATEMENTS


Basis of Presentation
The unaudited financial statements included herein have been prepared in
accordance with generally accepted accounting principles for interim financial
information and with the instructions to Form 10-QSB and Item 301(b) of
Regulation S-B. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements.  In the opinion of management, all adjustments
(consisting of normal recurring accruals) considered necessary for a fair
presentation have been included.  Operating results for the three months ended
March 31, 2001 and 2000 are not necessarily indicative of the results that may
be expected for the years ended December 31, 2001 and 2000. The December 31,
2000 balance sheet was derived from audited financial statements, but does not
include all disclosures required by generally accepted accounting principles.
Certain information and note disclosures normally included in financial
statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and
regulations relating to interim consolidated financial statements. For further
information, the statements should be read in conjunction with the financial
statements and notes thereto included in the Company's registration statement
on Form 10KSB.

The Company adopted Financial Accounting Standards  (SFAS) No.  128,
"Earnings Per Share," which simplifies the computation of earnings per share
requiring the restatement of all prior periods. Basic earnings per share are
computed on the basis of the weighted average number of common shares
outstanding during each year. Diluted earnings per share are computed on the
basis of the weighted average number of common shares and dilutive securities
outstanding.  Dilutive securities having an anti-dilutive effect on diluted
earnings per share are excluded from the calculation.

Organization
The  Company (formerly Golden Maple Mining and Leaching Co., Inc.) was
incorporated under the laws of the State of Montana on August 13, 1981.  The
Company ceased its mining operations in 1985, and discontinued all business
operations in 1990.  On May 23, 1998, the Company acquired all the common
stock of Consolidated Medical Management, Inc. (a private Louisiana
corporation, hereafter sometimes referred to as "CMMI-LA" or "subsidiary") in
a stock for stock exchange transaction, whereupon, CMMI-LA became a wholly
owned subsidiary of the Company.  These financial statements reflect the
financial condition and results of operations for the consolidated Company,
retroactively stated as if the acquisition had occurred at the beginning of
the current fiscal period.

The subsidiary provided management services for home healthcare providers
predominately in southern Louisiana.  The Company's subsidiary, Independent
Diagnostic Services, Inc., provides diagnostic ultrasound imaging services to
physician offices, clinics, hospital and skilled nursing facilities, and also
provides mobile laboratories that will enable services to be provided for
communities with limited access to technologists, hospitals and diagnostic
laboratories.  The Company has formed a subsidiary, Psychiatric Medical Services
, Inc. ("PMSI") to operate a partial-unit mental services hospital in an
existing hospital environment.  As of December 31, 1999, all operating
activities have ceased due to the fact that a contract with a major customer
was cancelled in August of 1999.


Consolidated Medical Management, Inc.
             NOTES TO FINANCIAL STATEMENTS


Principles of Consolidation
The consolidated financial statements include the accounts of Consolidated
Medical Management, Inc. (a Montana Corporation), and its subsidiaries,
Independent Diagnostic Services, Inc. and Psychiatric Management Services,
Inc.. The Company and its subsidiaries provide health care services
specializing in mobile diagnostic imaging and the operation of a part-hospital
psychiatric unit and therefore extend credit to the health care providers
involved with the patients served.

NOTE 1  -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting policies of the Company conform with the generally accepted
accounting principles and reflect practices appropriate to the industry in
which it operates.  The significant policies are summarized below.

-     Property, Equipment and Depreciation  - Due to the Companies lack of
business, the Company has disposed of all assets it owned as of March 31,
2001. The resulting value of  $17,415 has been written off to Other Income and
Expenses for the current quarter.

-     Risks and Uncertainties  -  The preparation of financial statements in
conformity with generally accepted accounting principles requires management
to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the
date of financial statements and the reported amounts of revenues and expenses
during the reported period.  Actual results could differ from those estimates.

NOTE 2  -  NOTES PAYABLE


Note payable to GE Capital, financing the phone system,
in the original amount of $ 10,222,
dated September 16, 1997,  payable in thirty-nine
installments of $341 with  interest at 12.5%,
secured by a pledge of the  phone system.


                                                 $       3,760

Six  (6) notes payable to Spectrum Financial, Inc., a
related party of the Company, dated September 29,1998,
due July 29, 2000, interest at 10%, payable on maturity,
unsecured


                                                        76,733

Total Notes Payable                                     80,493
     Less Current
Portion                                                (25,767)
Long Term Portion                                $      54,726

        Maturities of Notes Payable over the next five years are:
               2001                              $       80,493
               2001 and thereafter                           -0-
                                                 $       80,493


Consolidated Medical Management, Inc.
NOTES TO FINANCIAL STATEMENTS

NOTE 3  -  CONVERTIBLE DEBENTURES AND NOTES PAYABLE

The Company issued convertible debentures in 1998 that are subordinated to
bank debt and secured leases.  The debentures are otherwise unsecured but are
given a preference over unsecured debt. The debentures include interest at
fifteen (15%) percent, interest is payable in monthly installments.  Each
debenture has a conversion right for each holder to convert the debenture
principal to shares of the Company's common stock at the greater of $2.50 per
share or sixty (60%) percent of the bid price, whichever is greater on the
date of conversion.  Accrued interest and any principal amount not converted
to shares of stock will be paid in cash at conversion.  The company had issued
and outstanding $190,000 in debentures.  The debentures are due one year from
date of issue. All debentures issued in 1998 were due in 1999.

The Company issued convertible promissory notes payable in 1998.  The notes
are unsecured and include interest at ten (10%) percent, interest is payable
in monthly installments.  Each note has a conversion right for each holder to
convert the note's unpaid principal to shares of the Company's common stock
based on $2.50 per share, or a total of 90,000 at the note holder's
discretion.  Accrued interest and any principal amount not converted to shares
of stock will be paid in cash at conversion. The company had issued and
outstanding $325,000 in notes payable.  The notes were due July 31, 1999.

The Company has entered into an agreement with Spectrum Financial, Inc.
("Spectrum") whereby Spectrum will exchange shares it owns with the debenture
holder upon exercise of the debenture's conversion option, in satisfaction of
the Company's obligations under the conversion provisions.  In exchange,
Spectrum will then receive an unsecured note payable from the Company (see
Note 7) for the face amount of the debenture surrendered.

     Total Convertible Debentures and Notes Payable          $       465,000
     Less: Current Portion                                          (465,000)
     Long-Term Portion                                       $            -0-

NOTE 4  -  COMMON AND PREFERRED STOCK

Common Stock

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of March 31, 2001.  As of March 31, 2001, the Company had
10,626,247 shares issued and outstanding, respectively.

Previously the Company had issued 4,000,000 shares of common stock to Douglas
Kemp, its President and CEO. On May 16, 2001, the Company approved a
resolution to cancel those shares and to reverse out the accrual of his unpaid
salary from the year 2000 and 2001.

The Company also cancelled the 400,000 shares of common stock to Jack London
and reversed out the $400,000 in Acquisition Costs that was written off to
Other Income as of December 31, 2000.

Consolidated Medical Management, Inc.
NOTES TO FINANCIAL STATEMENTS


NOTE 4  -  COMMON AND PREFERRED STOCK (CONTINUATION)

Preferred Stock

In 1998, the Company amended its articles to authorize Preferred Stock.  There
are 20,000,000 shares authorized with a par value of $ 0.001.  The shares are
non-voting and non-redeemable by the Company.  The Company further designated
two series of its Preferred Stock:  "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00
Preferred Stock," with the number of authorized shares set at 1,079,957
shares.  As of March 31, 2001 there are no shares issued and outstanding.

Dividends - Dividends are non-cumulative, however, the holders of such series,
in preference to the holders of any common stock, shall be entitled to
receive, as and when declared payable by the Board of Directors from funds
legally available for the payment thereof, dividends in lawful money of the
United States of America at the rate per annum fixed and determined as herein
authorized for the shares of such series, but no more, payable quarterly on
the last days of March, June, September, and December in each year with
respect to the quarterly period ending on the day prior to each such
respective dividend payment date.  In no event shall the holders of either
series receive dividends of more than percent (1%) in any fiscal year.  Each
share of both series shall rank on a party with each other share of preferred
stock, irrespective of series, with respect to dividends at the respective
fixed or maximum rates for such series.

Conversion provisions- Any holder of either series may convert any or all of
such shares into shares of common stock of the Company at any time. Said
shares shall be convertible at a rate equal to three (3) shares of common
stock of the Company for each one (1) share of Series "A" of $ 12.50 Preferred
Stock.  The Series "A" $12.50 Preferred Stock shall be convertible, in whole
or in part, at any time after the common stock of the Company shall maintain
an average bid price per share of at least $12.50 for ten (10) consecutive
trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock.  The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for
ten (10) consecutive trading days.

The preferential amount payable with respect to shares of either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share, plus
the amount of any dividends declared and unpaid thereon.



Consolidated Medical Management, Inc.
NOTES TO FINANCIAL STATEMENTS


NOTE 5  -  COMMITMENTS AND CONTINGENCIES

There exist some contingencies that the Company may be exposed to additional
liabilities that are not recorded on the Balance Sheet. One, the Company
issued notes payable to two Organizations that were to be acquired. The
balance of the notes payable is $438,000, but the Company has refused to honor
these notes because the acquiring Organizations did not honor their
contractual agreement to provide necessary information to the Company.
Secondly, the Company in indebted to the Organization that the Company had
subleased the imaging equipment. Since the Organization picked up three of the
four units, the Company removed the liabilities from its Balance Sheet. Total
contingent liabilities from the equipment leases that was written off is $
211,370.

The Company had previously agreed to pay Douglas Kemp salary for 24 months
after his dismissal. The Company does not plan to honor this agreement due to
non-performance of his employment contract.


NOTE  6 -  OTHER INCOME AND EXPENSES

Details of the Other Income and expenses for the quarter ended March 31, 2001
is as follows:

          Reversal of Salary Accrual for Douglas Kemp     $ 141,802
          Cancellation of Common Shares for Douglas Kemp      4,000
          Disposal of Fixed Assets                          (17,415)
          Cancellation of Common Shares for Jack London     400,000

          Total                                          $  528,387









[ THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY.]








ITEM 2.    MANAGEMENT'S DISCUSSION AND ANALYSIS
                OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in combination with
Management's Discussion and Analysis of Financial Condition and Results of
Operations in Item 6 of the 2000 Form 10-KSB, the financial statements and
notes contained in Item 7 of the 2000 Form 10-KSB and the interim financial
statements and notes thereto contained elsewhere in this Report.

Certain statements set forth in this discussion and analysis of financial
condition and results of operations including anticipated store openings,
planned capital expenditures and trends in or expectations regarding the
Company's operations constitute "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
statements are based on currently available operating, financial and
competitive information and are subject to various risks and uncertainties.
Actual future results and trends may differ materially depending on a variety
of factors as set forth herein.

RESULTS OF OPERATIONS

-     For the Three-Month Period Ended  March 31, 2000

The Company recognized net loss of ($101,606), (with loss per share of
($0.0106) per common share).  During this period, the Company has only limited
operation due to the fact that contracts were lost with a major customer in
1999 and they only have one piece of equipment to perform medical treatments.
For the period ended March 31, 2000, the Company recognized the operations of
its wholly-owned subsidiaries, Independent Diagnostic Services, Inc. and
Psychiatric Management Services, Inc. (PMSI) with consolidated operating
revenue of $76,287 for the three-month period ended June 30, 2000.

For the three-month period ended March 31, 2000, the Company incurred
operating costs associated with the production of revenue totaling $158,926.
The most significant elements of operating expenses are personnel costs
totaling $68,928 for the quarter.  Personnel costs include professional wages
of the personnel who deliver the health-care services required by the
contracts and related administrative salaries and benefits.  In the quarter,
the Company incurred legal and professional fees totaling $50,175 primarily
associated with filings and legal matters on stock related issues. The Company
incurred office expense totaling $25,603 for the three-month period.


-     For the Three-Month Period Ended March 31, 2001

The Company recognized net income of $489,968, (with income per share of
$0.0444 per common share). The net income is related primarily to the
cancellation of common stock and reversal of salary accrued in 2000

There were no operating revenues during the quarter and the only operating
expenses were professional fees and $1,429 in office expenses.


FINANCIAL CONDITION

Liquidity and Capital Resources

As of March 2001, the Company cancelled 4,400,000 shares of common stock and
recognized a $404,000 used from Financing Activities.

The Company has a cash balance of $528 as of March 31, 2001 and a working
capital deficit of ($776,332)

The Company's accounts payable and accrued expenses total $286,093 as of March
31, 2001.   The Company's obligations under these accounts have aged since
December 31, 2000, with $261,093 of these amounts owed for more than ninety
days.











[ THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY.]









P A R T   II

OTHER INFORMATION

ITEM 2.    CHANGES IN SECURITIES AND USE OF PROCEEDS

Since the end of the fiscal year ended December 31, 2000, and through the end
of the quarter ended March 31, 2001, the Company has not issued any shares of
common stock of the company without registration under the Securities Act of
1993.

All of the aforesaid securities set forth immediately above were issued
without registration under the Act by reason of the exemption from
registration afforded by the provisions of Section 4(2) thereof, as
transactions by an issuer not involving any public offering, each recipient of
securities having delivered appropriate investment representations to
Registrant with respect thereto and having consented to the imposition of
restrictive legends upon the certificates evidencing such securities.  No
underwriting discounts of commission were paid in connection with such
issuances.


ITEM 5.    OTHER INFORMATION
(a)     The following table sets forth the current executive officers and
directors of the Company:
                                      Director
Name                     Age          Position(s)               Since
Peggy D. Behrens          44          Director and Secretary     1998
Lynn Simon, M.D.          49          Director                   1998

(b) There are no significant employees other than executive officers above.

(c) There are no family relationships among directors or executive officers of
the Company.


ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K

(a)     Exhibits.  The following exhibits are included as part of this report.

Exhibit  No     Description of Exhibit
     None

(b)     No reports on Form 8-K were filed during the quarter covered by this
report.








SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Consolidated Medical Management, Inc.



By - Peggy Behrens - Secretary
(Principal Accounting Officer)


Date: May 16, 2001`